HCAT vs OMCL
HCAT: Health Catalyst provides cloud-based data analytics and improvement services to healthcare systems, but faces significant headwinds from customer financial strain, platform migration challenges, and macroeconomic pressures on healthcare budgets. OMCL: Omnicell automates medication management across healthcare settings through storage, dispensing, and intelligence solutions to enable safer, more efficient pharmacy operations.
Side-by-side fundamentals
| Metric | HCAT | OMCL | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $2.15 | $41.49 | |
| Market cap as of 2026-07-29 | $157M | $1.9B | |
| P/E as of 2026-07-29 | n/a | 94.06 | |
| PEG as of 2026-07-29 | -0.00 | 2.94 | HCAT lower |
| Net margin as of 2026-07-29 | -87.7% | +1.7% | OMCL higher |
| Gross margin as of 2026-07-29 | +50.4% | +43.5% | HCAT higher |
| Operating margin as of 2026-07-29 | -81.7% | +2.8% | OMCL higher |
| ROE as of 2026-07-29 | -99.8% | +1.6% | OMCL higher |
| ROA as of 2026-07-29 | -50.1% | +1.0% | OMCL higher |
| Debt / equity as of 2026-07-29 | 1.11 | 0.13 | OMCL lower |
| Revenue growth (YoY) as of 2026-07-29 | -2.8% | +7.9% | OMCL higher |
| Revenue CAGR (3y) SEC XBRL | +4.0% | -2.9% | HCAT higher |
| Beta as of 2026-07-29 | 1.54 | 0.96 | |
| 1-year return as of 2026-07-27 close | -44.6% | +46.8% | OMCL higher |
Fundamentals: Finnhub, as of 2026-07-29. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.